1,1'-(Piperazine-1,4-diyl)bis(3-bromopropan-1-one), 95.0%, 1g

2,4,6-TRIMETHYL-1,3,5-TRIPROPYL-1,3,5,2,4,6-TRIAZATRIBORINANE, 95.0%, 250mg

N-[4-(4-methylpiperazin-1-yl)-3'-[(morpholin-4-yl)methyl]-[1,1'-biphenyl]-3-yl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide, 95%, 5mg

2-Aminopent-4-en-1-ol hydrochloride, 97%, 100mg

5-Bromo-2-methylbenzamide, 95+%, 1g

tert-Butyl 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[4.1.0]heptane-3-carboxylate, 98%, 1g

tert-Butyl methyl(prop-2-yn-1-yl)carbamate, 97%, 10g

SIVELESTAT, 95%, 100mg

5-Bromo-4,6-dichloropyrimidine, 96.0%, 1g

Double neck round bottom flasks, 500 ml, 24/29, 14/23, 1 Piece

Filtration unit with SFCA membrane Pore size 0.45 μm, 150 ml, 150 ml, 50 mm, 12 Piece(s)

D-ValNH2.HCl, 95.0%, 10g

Dipropyl Malonate>98.0%(GC)25g